137 related articles for article (PubMed ID: 12362278)
1. Clinical impact of novel treatment strategies.
Giaccone G
Oncogene; 2002 Oct; 21(45):6970-81. PubMed ID: 12362278
[TBL] [Abstract][Full Text] [Related]
2. Novel therapies for the treatment of non-small cell lung cancer.
Johnson DH; Schiller JH
Cancer Chemother Biol Response Modif; 2002; 20():763-86. PubMed ID: 12703233
[TBL] [Abstract][Full Text] [Related]
3. Advanced NSCLC: from cytotoxic systemic chemotherapy to molecularly targeted therapy.
Hoang T; Schiller JH
Expert Rev Anticancer Ther; 2002 Aug; 2(4):393-401. PubMed ID: 12647982
[TBL] [Abstract][Full Text] [Related]
4. Current immunotherapeutic strategies in lung cancer.
Rüttinger D; Hatz RA; Jauch KW; Fox BA
Surg Oncol Clin N Am; 2007 Oct; 16(4):901-18, x. PubMed ID: 18022551
[TBL] [Abstract][Full Text] [Related]
5. The role of targeted therapy in non-small cell lung cancer.
Maione P; Rossi A; Airoma G; Ferrara C; Castaldo V; Gridelli C
Crit Rev Oncol Hematol; 2004 Jul; 51(1):29-44. PubMed ID: 15207252
[TBL] [Abstract][Full Text] [Related]
6. Alternatives to chemotherapy and radiotherapy in the treatment of small cell lung cancer.
Shepherd FA
Semin Oncol; 2001 Apr; 28(2 Suppl 4):30-7. PubMed ID: 11479895
[TBL] [Abstract][Full Text] [Related]
7. The role of new targeted therapies in small-cell lung cancer.
Rossi A; Maione P; Colantuoni G; Guerriero C; Gridelli C
Crit Rev Oncol Hematol; 2004 Jul; 51(1):45-53. PubMed ID: 15207253
[TBL] [Abstract][Full Text] [Related]
8. New biological agents in the treatment of advanced non-small cell lung cancer.
Morrow PK; Kim ES
Semin Respir Crit Care Med; 2005 Jun; 26(3):323-32. PubMed ID: 16052434
[TBL] [Abstract][Full Text] [Related]
9. Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy.
Gridelli C; Rossi A; Maione P; Ferrara ML; Castaldo V; Sacco PC
Oncologist; 2009 Sep; 14(9):909-20. PubMed ID: 19726457
[TBL] [Abstract][Full Text] [Related]
10. New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor.
Crawford J
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S78-86. PubMed ID: 19795580
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for advanced non-small-cell lung cancer.
Raez LE; Lilenbaum R
Clin Adv Hematol Oncol; 2004 Mar; 2(3):173-8. PubMed ID: 16166948
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic therapy in nonsmall cell lung cancer.
Gutierrez M; Giaccone G
Curr Opin Oncol; 2008 Mar; 20(2):176-82. PubMed ID: 18300767
[TBL] [Abstract][Full Text] [Related]
13. The emerging role of vascular endothelial growth factor receptor tyrosine kinase inhibitors.
Langer CJ; Natale RB
Semin Oncol; 2005 Dec; 32(6 Suppl 10):S23-9. PubMed ID: 16459176
[TBL] [Abstract][Full Text] [Related]
14. Targeting lethal minimal residual disease in small cell lung cancer.
Patel JD; Krug LM; Azzoli CG; Gomez J; Kris MG; Miller VA
Semin Oncol; 2003 Feb; 30(1):79-85. PubMed ID: 12635092
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapies for non-small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective.
Raben D; Helfrich B; Bunn PA
Int J Radiat Oncol Biol Phys; 2004; 59(2 Suppl):27-38. PubMed ID: 15142632
[TBL] [Abstract][Full Text] [Related]
16. Targeting non-small cell lung cancer with epidermal growth factor tyrosine kinase inhibitors: where do we stand, where do we go.
Patel JD; Pasche B; Argiris A
Crit Rev Oncol Hematol; 2004 Jun; 50(3):175-86. PubMed ID: 15182824
[TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibitors in lung cancer.
Scagliotti G
Crit Rev Oncol Hematol; 2006 Jun; 58(3):177-89. PubMed ID: 16427303
[TBL] [Abstract][Full Text] [Related]
18. Small cell lung cancer and targeted therapies.
Blackhall FH; Shepherd FA
Curr Opin Oncol; 2007 Mar; 19(2):103-8. PubMed ID: 17272981
[TBL] [Abstract][Full Text] [Related]
19. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Introduction.
Bunn PA; Thatcher N
Oncologist; 2008; 13 Suppl 1():1-4. PubMed ID: 18263768
[TBL] [Abstract][Full Text] [Related]
20. Targeting receptor tyrosine kinase signalling in small cell lung cancer (SCLC): what have we learned so far?
Fischer B; Marinov M; Arcaro A
Cancer Treat Rev; 2007 Jun; 33(4):391-406. PubMed ID: 17368733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
